OSU-T315 as an Interesting Lead Molecule for Novel B Cell-Specific Therapeutics

about

OSU-T315 as an Interesting Lead Molecule for Novel B Cell-Specific Therapeutics

Item

http://www.wikidata.org/entity/Q57112652

description

scientific article published on 12 September 2018

@en

wetenschappelijk artikel

@nl

наукова стаття, опублікована у 2018

@uk

name

OSU-T315 as an Interesting Lead Molecule for Novel B Cell-Specific Therapeutics

@en

OSU-T315 as an Interesting Lead Molecule for Novel B Cell-Specific Therapeutics

@nl

type

Item

label

OSU-T315 as an Interesting Lead Molecule for Novel B Cell-Specific Therapeutics

@en

OSU-T315 as an Interesting Lead Molecule for Novel B Cell-Specific Therapeutics

@nl

prefLabel

OSU-T315 as an Interesting Lead Molecule for Novel B Cell-Specific Therapeutics

@en

OSU-T315 as an Interesting Lead Molecule for Novel B Cell-Specific Therapeutics

@nl

P1476

OSU-T315 as an Interesting Lead Molecule for Novel B Cell-Specific Therapeutics

@en

P2093

Jean Herman

http://www.w3.org/2001/XMLSchema#string

Mark Waer

http://www.w3.org/2001/XMLSchema#string

P2860

B cells with regulatory properties in transplantation tolerance

Reprint of: B cells in chronic graft-versus-host disease

Integrin-linked kinase (ILK) is required for polarizing the epiblast, cell adhesion, and controlling actin accumulation

Reduced chondrocyte proliferation and chondrodysplasia in mice lacking the integrin-linked kinase in chondrocytes

Integrin-linked kinase is required for epidermal and hair follicle morphogenesis.

The small molecule inhibitor QLT0267 Radiosensitizes squamous cell carcinoma cells of the head and neck.

The ILK/PINCH/parvin complex: the kinase is dead, long live the pseudokinase!

Identification and characterization of a novel integrin-linked kinase inhibitor

Targeted deletion of integrin-linked kinase reveals a role in T-cell chemotaxis and survival.

Pathogenesis of human B cell lymphomas.

P304

2505818

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1155/2018/2505818

http://www.w3.org/2001/XMLSchema#string

P407

English

P478

2018

http://www.w3.org/2001/XMLSchema#string

P50

Ben Sprangers

Thierry Louat

Kristien Van Belle

P577

2018-09-12T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

30276218

http://www.w3.org/2001/XMLSchema#string

P921

immunology

P932

6157143

http://www.w3.org/2001/XMLSchema#string